Several top-tier hospitals in Shanghai have recently introduced MRI-guided focused ultrasound (MRgFUS) technology for the non-invasive treatment of uterine fibroids. According to clinical data, this technology uses real-time MRI guidance to precisely focus extracorporeal ultrasound waves on fibroid tissue, causing coagulation necrosis without the need for incisions or punctures. To date, multiple patients have been successfully treated, with an average reduction in fibroid volume of approximately 40% and significant improvement in symptoms.
This technology is suitable for single or multiple uterine fibroids with a diameter not exceeding 10 cm, and is particularly beneficial for women with fertility desires, as the treatment preserves the integrity of the uterus, allows for rapid postoperative recovery, and typically enables discharge the next day. The treatment procedure takes approximately 2-3 hours, requiring no anesthesia, only sedation.
Background and Significance
Uterine fibroids are the most common benign tumors in women of reproductive age, with an incidence rate as high as 20%-40%. Traditional treatment methods include medication, surgical removal of fibroids, or hysterectomy. The advent of MRgFUS offers new possibilities for non-invasive treatment. Compared to traditional surgery, this technology involves no incisions, no bleeding, and no scarring, and causes minimal damage to the uterine muscle layer, reducing the risk of postoperative adhesions and pregnancy complications. According to international studies, the post-treatment pregnancy rate can reach 30%-40%, with favorable fetal outcomes. The introduction of this technology marks a significant step forward in the precise and non-invasive treatment of uterine fibroids.
Significance for International Patients
For international patients, MRgFUS is particularly attractive for several reasons: first, it avoids surgical trauma, shortens recovery time, and reduces medical costs; second, it preserves the uterus, meeting fertility needs; third, the treatment process is comfortable, allowing for a quick return to normal life. However, this technology requires high-level equipment and physician expertise, and only a few medical centers worldwide can provide it. Shanghai, China, boasts advanced MRgFUS equipment and experienced expert teams, with treatment costs approximately 40%-60% lower than those in European and American countries, making it a new choice for international patients seeking high-quality medical care.
How MedBridge Can Help
MedBridge Shanghai specializes in cross-border medical services, providing one-stop services for international patients. We can assist in scheduling appointments with MRgFUS specialists at partner hospitals in Shanghai, arranging detailed preoperative evaluations (including MRI scans), and providing treatment cost estimates and insurance coordination. Additionally, we offer full translation services, visa support, and accommodation and transportation arrangements to ensure patients receive care with peace of mind. Interested individuals can contact us via Contact Us or use the Cost Estimator to obtain a personalized quote. Our Medical Services page details the specialties and technologies covered.
Related reading: Overview of Partner Hospitals in Shanghai